Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.
Vaccine
; 31(35): 3577-84, 2013 Aug 02.
Article
en En
| MEDLINE
| ID: mdl-23688526
Palabras clave
13-valent pneumococcal conjugate vaccine; 23-valent polysaccharide vaccine; 7-valent pneumococcal conjugate vaccine; AE; Adult; CI; CRM197; GMR; GMT; IPD; LLOQ; LOD; OPA; PCV; PCV13; PCV7; PPSV23; Pneumococcal conjugate vaccine; Pneumonia; RCDC; SAE; adverse event; confidence interval; cross-reactive material 197; geometric mean ratio; geometric mean titer; invasive pneumococcal disease; limit of detection; lower limit of quantitation; opsonophagocytic activity; pneumococcal polysaccharide conjugate vaccine; reverse cumulative distribution curve; serious adverse event
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neumonía Neumocócica
/
Streptococcus pneumoniae
/
Vacunas Conjugadas
/
Vacunas Neumococicas
Tipo de estudio:
Clinical_trials
Límite:
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Vaccine
Año:
2013
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Países Bajos